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The EU food labelling regulation tells the food producer
that all ingredients in a pre-packaged product need to
b ei nt h el i s to fi n g r e d i e n t s .T h e r ea r es o m ee x c e p t i o n s
from this general rule, but theses exceptions can not be
used if the ingredient is a recognised allergenic food on
the EU list. It is also important to note that the produ-
cer is obliged to use an easily recognisable name. As an
example it is not sufficient to write casein on the list of
ingredients, because consumers may not know that
casein is a milk ingredient. The producer must write e.g.
casein (milk). This regulation only covers pre-packaged
food and not food sold loose or in restaurants. This
type of food is one of the leading causes of severe aller-
gic reactions in people. The European Council adopted
in December 2010 an opinion stating that allergen infor-
mation on non pre-packaged food should be ‘manda-
tory’.I ft h i sp r o p o s a li sa g r e e du p o nb yt h eE U
parliament it will be a great advantage for food allergic
persons but also a big challenge for small businesses
preparing foods sold loose e.g. in bakeries or served in
restaurants. Current EU legislation also has not
addressed directly the issue of allergen cross contamina-
tion. Whilst there is some voluntary guidance which
includes qualitative advice for industry on how to assess
and manage risk from allergenic foods, there is currently
no advice from regulatory bodies or compliance authori-
ties on levels of allergen cross contamination above
which advisory labelling (such as ‘May Contain Nuts’)
should be used. This current absence of defined thresh-
olds has consequences for risk managers, who have to
decide what level of allergenic food in a given product
constitutes a health risk and therefore requires action to
manage and/or communicate the risk.
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